Davide Bassani

810 total citations
29 papers, 514 citations indexed

About

Davide Bassani is a scholar working on Molecular Biology, Computational Theory and Mathematics and Infectious Diseases. According to data from OpenAlex, Davide Bassani has authored 29 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Computational Theory and Mathematics and 7 papers in Infectious Diseases. Recurrent topics in Davide Bassani's work include Computational Drug Discovery Methods (12 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Protein Structure and Dynamics (6 papers). Davide Bassani is often cited by papers focused on Computational Drug Discovery Methods (12 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Protein Structure and Dynamics (6 papers). Davide Bassani collaborates with scholars based in Italy, Switzerland and United States. Davide Bassani's co-authors include Stefano Moro, Matteo Pavan, Mattia Sturlese, Giovanni Bolcato, Camilla Pecoraro, Stella Cascioferro, Valentina Gandin, Girolamo Cirrincione, Michele De Franco and Barbara Parrino and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Science Translational Medicine.

In The Last Decade

Davide Bassani

27 papers receiving 503 citations

Peers

Countries citing papers authored by Davide Bassani

Since Specialization

Citations

This map shows the geographic impact of Davide Bassani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Bassani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Bassani more than expected).

Fields of papers citing papers by Davide Bassani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Bassani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Bassani. The network helps show where Davide Bassani may publish in the future.

Co-authorship network of co-authors of Davide Bassani

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Bassani. A scholar is included among the top collaborators of Davide Bassani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Bassani. Davide Bassani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Leveraging machine learning predicted confidence for boosting assay submission and decision-making efficiencies 2025 ·European Journal of Medicinal Chemistry ·Davide Bassani, Michael Reutlinger, Holger Fischer	0
2	Another string to your bow: machine learning prediction of the pharmacokinetic properties of small molecules 2024 ·Expert Opinion on Drug Discovery ·Davide Bassani, Neil Parrott, Nenad Manevski, Jitao David Zhang	11
3	7-Amino-[1,2,4]triazolo[1,5-a][1,3,5]triazines as CK1δ inhibitors: Exploring substitutions at the 2 and 5-positions 2024 ·Bioorganic Chemistry ·(unknown), Davide Bassani, (unknown), Veronica Salmaso, (unknown), Filippo Prencipe, Tatiana Da Ros, Loreto Martínez‐González, Ana Martı́nez, Giampiero Spalluto, Stefano Moro, Stephanie Federico	0
4	Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors 2023 ·ChemMedChem ·Teresa Gianferrara, Matteo Pavan, Davide Bassani, Fabrizio Vincenzi, Silvia Pasquini, Giovanni Bolcato, (unknown), Giampiero Spalluto, Stephanie Federico, Stefano Moro	3
5	“Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies 2023 ·Pharmaceuticals ·Andrea Spinaci, Michela Buccioni, Daniela Catarzi, Chang Cui, Vittoria Colotta, Diego Dal Ben, (unknown), (unknown), (unknown), Catia Lambertucci, Gabriella Marucci, Davide Bassani, Matteo Pavan, Flavia Varano, Stephanie Federico, Giampiero Spalluto, Stefano Moro, Rosaria Volpini	9
6	Molecular Modeling Unveils the Effective Interaction of B-RAF Inhibitors with Rare B-RAF Insertion Variants 2023 ·International Journal of Molecular Sciences ·Maria Chiara Scaini, Luisa Piccin, Davide Bassani, Antonio Scapinello, (unknown), (unknown), (unknown), (unknown), Jacopo Pigozzo, Luigi Dall’Olmo, Antonio Rosato, Stefano Moro, Vanna Chiarion‐Sileni, Chiara Menin	4
7	Physiologically Based Biopharmaceutics Modeling of Food Effect for Basmisanil: A Retrospective Case Study of the Utility for Formulation Bridging 2023 ·Pharmaceutics ·(unknown), Davide Bassani, Cordula Stillhart, Neil Parrott	8
8	1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: Synthesis and pharmacological evaluation 2023 ·European Journal of Medicinal Chemistry ·Camilla Pecoraro, Michele De Franco, Daniela Carbone, Davide Bassani, Matteo Pavan, Stella Cascioferro, Barbara Parrino, Girolamo Cirrincione, Stefano Dall’Acqua, Stefano Moro, Valentina Gandin, Patrizia Diana	30
9	Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma 2023 ·Marine Drugs ·Daniela Carbone, Michele De Franco, Camilla Pecoraro, Davide Bassani, Matteo Pavan, Stella Cascioferro, Barbara Parrino, Girolamo Cirrincione, Stefano Dall’Acqua, Stefania Sut, Stefano Moro, Valentina Gandin, Patrizia Diana	23
10	Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies 2023 ·Molecules ·Davide Bassani, Stefano Moro	64
11	Federated Learning in Computational Toxicology: An Industrial Perspective on the Effiris Hackathon 2023 ·Chemical Research in Toxicology ·Davide Bassani, Alessandro Brigo, (unknown)	8
12	Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal Adenocarcinoma 2023 ·International Journal of Molecular Sciences ·Daniela Carbone, Michele De Franco, Camilla Pecoraro, Davide Bassani, Matteo Pavan, Stella Cascioferro, Barbara Parrino, Girolamo Cirrincione, Stefano Dall’Acqua, Stefano Moro, Valentina Gandin, Patrizia Diana	30
13	SARS-CoV-2 3CL ^pro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376 2022 ·Science Translational Medicine ·Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi, Chengjin Ye, Matteo Pavan, Davide Bassani, André Volland, (unknown), Alexander K. H. Weiss, David Bante, Reuben S. Harris, Stefano Moro, Bernhard Rupp, Luis Martínez‐Sobrido, Dorotheé von Laer	69
14	Omicron Variant of SARS-CoV-2 Virus: In Silico Evaluation of the Possible Impact on People Affected by Diabetes Mellitus 2022 ·Frontiers in Endocrinology ·Davide Bassani, Eugenio Ragazzi, Annunziata Lapolla, Giovanni Sartore, Stefano Moro	8
15	Implementing a Scoring Function Based on Interaction Fingerprint for Autogrow4: Protein Kinase CK1δ as a Case Study 2022 ·Frontiers in Molecular Biosciences ·Matteo Pavan, (unknown), Davide Bassani, Mattia Sturlese, Stefano Moro	19
16	Sodium or Not Sodium: Should Its Presence Affect the Accuracy of Pose Prediction in Docking GPCR Antagonists? 2022 ·Pharmaceuticals ·Davide Bassani, Matteo Pavan, Mattia Sturlese, Stefano Moro	6
17	Computational Strategies to Identify New Drug Candidates againstNeuroinflammation 2022 ·Current Medicinal Chemistry ·Matteo Pavan, Davide Bassani, Giovanni Bolcato, Maicol Bissaro, Mattia Sturlese, Stefano Moro	6
18	From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19? 2022 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Matteo Pavan, Davide Bassani, Mattia Sturlese, Stefano Moro	13
19	In silico evaluation of the interaction between ACE2 and SARS-CoV-2 Spike protein in a hyperglycemic environment 2021 ·Scientific Reports ·Giovanni Sartore, Davide Bassani, Eugenio Ragazzi, Pietro Traldi, Annunziata Lapolla, Stefano Moro	13
20	Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332 2021 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Matteo Pavan, Giovanni Bolcato, Davide Bassani, Mattia Sturlese, Stefano Moro	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact